255 related articles for article (PubMed ID: 8453667)
1. The oncoprotein Bcl-3 directly transactivates through kappa B motifs via association with DNA-binding p50B homodimers.
Bours V; Franzoso G; Azarenko V; Park S; Kanno T; Brown K; Siebenlist U
Cell; 1993 Mar; 72(5):729-39. PubMed ID: 8453667
[TBL] [Abstract][Full Text] [Related]
2. Regulation of NFKB1 proteins by the candidate oncoprotein BCL-3: generation of NF-kappaB homodimers from the cytoplasmic pool of p50-p105 and nuclear translocation.
Watanabe N; Iwamura T; Shinoda T; Fujita T
EMBO J; 1997 Jun; 16(12):3609-20. PubMed ID: 9218802
[TBL] [Abstract][Full Text] [Related]
3. The oncoprotein Bcl-3 can facilitate NF-kappa B-mediated transactivation by removing inhibiting p50 homodimers from select kappa B sites.
Franzoso G; Bours V; Azarenko V; Park S; Tomita-Yamaguchi M; Kanno T; Brown K; Siebenlist U
EMBO J; 1993 Oct; 12(10):3893-901. PubMed ID: 8404857
[TBL] [Abstract][Full Text] [Related]
4. The candidate oncoprotein Bcl-3 is an antagonist of p50/NF-kappa B-mediated inhibition.
Franzoso G; Bours V; Park S; Tomita-Yamaguchi M; Kelly K; Siebenlist U
Nature; 1992 Sep; 359(6393):339-42. PubMed ID: 1406939
[TBL] [Abstract][Full Text] [Related]
5. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers.
Fujita T; Nolan GP; Liou HC; Scott ML; Baltimore D
Genes Dev; 1993 Jul; 7(7B):1354-63. PubMed ID: 8330739
[TBL] [Abstract][Full Text] [Related]
6. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
7. The proto-oncogene bcl-3 encodes an I kappa B protein.
Kerr LD; Duckett CS; Wamsley P; Zhang Q; Chiao P; Nabel G; McKeithan TW; Baeuerle PA; Verma IM
Genes Dev; 1992 Dec; 6(12A):2352-63. PubMed ID: 1459457
[TBL] [Abstract][Full Text] [Related]
8. Bcl-3, a member of the I kappa B proteins, has distinct specificity towards the Rel family of proteins.
Inoue J; Takahara T; Akizawa T; Hino O
Oncogene; 1993 Aug; 8(8):2067-73. PubMed ID: 8336935
[TBL] [Abstract][Full Text] [Related]
9. NF- kappa B2/p100 induces Bcl-2 expression.
Viatour P; Bentires-Alj M; Chariot A; Deregowski V; de Leval L; Merville MP; Bours V
Leukemia; 2003 Jul; 17(7):1349-56. PubMed ID: 12835724
[TBL] [Abstract][Full Text] [Related]
10. I kappa B alpha can localize in the nucleus but shows no direct transactivation potential.
Cressman DE; Taub R
Oncogene; 1993 Sep; 8(9):2567-73. PubMed ID: 8361766
[TBL] [Abstract][Full Text] [Related]
11. Human RelB (I-Rel) functions as a kappa B site-dependent transactivating member of the family of Rel-related proteins.
Bours V; Azarenko V; Dejardin E; Siebenlist U
Oncogene; 1994 Jun; 9(6):1699-702. PubMed ID: 8183565
[TBL] [Abstract][Full Text] [Related]
12. Rearranged NFKB-2 genes in lymphoid neoplasms code for constitutively active nuclear transactivators.
Chang CC; Zhang J; Lombardi L; Neri A; Dalla-Favera R
Mol Cell Biol; 1995 Sep; 15(9):5180-7. PubMed ID: 7651435
[TBL] [Abstract][Full Text] [Related]
13. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
14. The involvement of the candidate proto-oncogene NFKB2/lyt-10 in lymphoid malignancies.
Neri A; Fracchiolla NS; Migliazza A; Trecca D; Lombardi L
Leuk Lymphoma; 1996 Sep; 23(1-2):43-8. PubMed ID: 9021684
[TBL] [Abstract][Full Text] [Related]
15. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
16. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
Matthews JR; Watson E; Buckley S; Hay RT
Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
[TBL] [Abstract][Full Text] [Related]
17. Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Fujita T; Nolan GP; Ghosh S; Baltimore D
Genes Dev; 1992 May; 6(5):775-87. PubMed ID: 1577272
[TBL] [Abstract][Full Text] [Related]
18. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor kappa B and induces nuclear translocation of transcription factor NF-kappa B proteins for transcriptional activation.
Hirai H; Suzuki T; Fujisawa J; Inoue J; Yoshida M
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3584-8. PubMed ID: 8170951
[TBL] [Abstract][Full Text] [Related]
19. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
Naumann M; Nieters A; Hatada EN; Scheidereit C
Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
